Your browser doesn't support javascript.
loading
Relationship among psychotic features, benzodiazepine receptor agonists, and rehospitalization in patients with electroconvulsive therapy-responsive major depressive disorder: A retrospective 2-year observational study.
Umakoshi, Akise; Takeshima, Masahiro; Itoh, Yu; Yamamoto, Mari; Shibata, Nana; Ogasawara, Masaya; Ayabe, Naoko; Mishima, Kazuo.
Affiliation
  • Umakoshi A; Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, Japan.
  • Takeshima M; Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, Japan.
  • Itoh Y; Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, Japan.
  • Yamamoto M; Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, Japan.
  • Shibata N; Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, Japan.
  • Ogasawara M; Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, Japan.
  • Ayabe N; Department of Regional Studies and Humanities, Faculty of Education and Human Studies, Akita University, Akita, Japan.
  • Mishima K; Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, Japan.
Neuropsychopharmacol Rep ; 42(4): 449-456, 2022 12.
Article de En | MEDLINE | ID: mdl-35866441
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Trouble dépressif majeur / Électroconvulsivothérapie Type d'étude: Clinical_trials / Observational_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Neuropsychopharmacol Rep Année: 2022 Type de document: Article Pays d'affiliation: Japon
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Trouble dépressif majeur / Électroconvulsivothérapie Type d'étude: Clinical_trials / Observational_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Neuropsychopharmacol Rep Année: 2022 Type de document: Article Pays d'affiliation: Japon